VISFO
Knowledge base
Market Access Key Opinion Leaders (MAKOLs)
Refine your stakeholder engagement strategy and leverage Market Access Key Opinion Leader (MAKOL) expertise, influence and networks to drive evidence-based access and reimbursement strategies.
Definition and criteria
A well-recognized, highly respected and trusted expert with significant influence in their field. KOLs are often thought leaders and educators, whose perceptions are likely to impact the opinions and decisions of others in their professional network. To be considered a KOL, an individual may fulfill some or even all of the following criteria:
Criteria 1
Demonstrates a strong publication record in peer-reviewed journals, publishing on themes such as: unmet needs; disease and economic burden; cost-effectiveness and budget impact of current and emerging therapies; healthcare resource utilization; reimbursement and access challenges
Criteria 2
Consistently authors systematic reviews, guidelines, or meta-analyses
Criteria 3
A well-respected researcher, clinician, economist or health policy expert
Criteria 4
Involved in country-specific or regional policy development and health economics initiatives
Criteria 5
Criteria 6
Power your decision-making
with bespoke and intuitive intelligence boards
Visualize
VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in our fully interactive, AI-enhanced knowledge base. Teams can drill down from high-level strategy to granular evidence, surfacing the right information in seconds.
Identify
Interrogate integrated and enriched data from diverse sources to identify MAKOLs in your therapy area and markets of interest. Our analyses typically span 10 years, meaning we can help you accurately identify and geolocate thousands of thought leaders in your field.
Analyze
Confidently inform your engagement strategy by using sophisticated data analytics tools to:
Reveal MAKOL publication histories
- Develop a holistic understanding of each individual MAKOL’s expertise and areas of special interest using up to date bibliometrics alongside a relevant literature library for each individual.
- Gain in-depth knowledge of the latest trends, methodologies and evidence in market access research, alongside the factors that impact the adoption and reimbursement of therapies.
Map MAKOL geolocation and professional networks
- Inform territorial lines, facilitate clinical trial recruitment, and tailor communications to priorities relevant to specific MAKOLs by determining their geolocation.
- Understand information flow and locate hubs of expertise by identifying publication co-authors and mapping collaboration networks across specialties and locations (at institute, city, state, country and global level).
Understand individual MAKOL impact
- Leverage our proprietary MAKOL impact factors based on publication volume, currency, and authorship weight, to identify MAKOLs whose expertise and experience aligns most closely with your company’s specific needs and strategic imperatives.
- Select additional metrics including journal prestige, publication type, and co-author impact factor to further interrogate individual influence in your chosen topic area.
- Track impact factors longitudinally to indicate changes in activity over time.
Connect with digital leaders
- Use social listening outputs to identify digitally active MAKOLs who leverage online platforms to maximize reach and impact.
Maintain a clear view of the MAKOL landscape throughout the lifecycle of your product with user-defined data updates.
Use cases
How can this help your team...
Medical Affairs
Encourage collaboration between Medical Affairs teams and MAKOLs to facilitate understanding and communication of your therapy’s value to healthcare providers and other stakeholders
Partner with MAKOLs to co-author peer-reviewed publications and participate in advisory boards to highlight emerging trends and therapies
Guide post-approval studies
Market Access
Empower market access teams to create compelling value propositions that align with payer priorities
Develop evidence-based market access and reimbursement strategies
Build awareness of, and support for, your product among key stakeholders
Clinical Development
Identify and target patient subgroups with the highest unmet need
Guide drug development strategies and clinical trial design to incorporate endpoints relevant to market access, such as quality of life, healthcare resource utilization and cost-effectiveness
Define value drivers for your therapeutic area early, to anticipate payer requirements for clinical evidence
See it in action with an interactive demo
See how VISFO’s precision intelligence and collaborative approach ensures you have the right insights, at the right time, to make the best possible strategic decisions.
